Page 4 - Valuating News Today

MyJournals.org - Science - Energies, Vol. 16, Pages 4073: Evaluating the Techno-Economic Effect of Pricing and Consumption Parameters on the Power-to-Energy Ratio for Sizing Photovoltaic-Battery Systems: An Assessment of Prosumers in the Mediterranean Area (Energies)

MyJournals.org - Science - Remote Sensing, Vol. 15, Pages 2559: Evaluating the Consistency of Vegetation Phenological Parameters in the Northern Hemisphere from 1982 to 2015 (Remote Sensing)

Hypertension in Pacemaker Patients Global pivotal study evaluating the efficacy and safety of BackBeat CNT in adult patients with hypertension who are indicated for a pacemaker on track to start in... | May 12, 2023

TG6050 is an oncolytic virus derived from Transgene's Invir.IO® platform encoding interleukin-12 (IL-12) and an anti-CTLA4 antibody, with the potential to trigger a powerful antitumor immune response.

P R E S S R E L E A S E Transgene - First Patient Dosed in Phase I Trial Evaluating TG6050, a Novel IL-12-Armed Oncolytic Virus Administered... | May 10, 2023

Montrouge, France, May 10, 2023 DBV Technologies Announces New England Journal of Medicine Publication of Phase 3 EPITOPE Trial Data Evaluating Viaskin Peanut in Toddlers The New

- Enrollment of pivotal Phase 3 SAPPHIRE trial evaluating apitegromab on track for completion in 2023 - Upcoming presentations of 36-month apitegromab data from Phase 2 TOPAZ trial at Cure... | May 9, 2023

New Data from Interim Analysis of Verastem Oncology’s RAMP 201 Trial Evaluating Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer to be Presented at the American Society... | May 9, 2023

Premier, Inc. , a leading technology-driven healthcare improvement company, today announced that its Board of Directors is evaluating potential strategic alternatives to enhance value for... | May 8, 2023

Premier Inc said on Monday its board was evaluating strategic alternatives and had established a special committee of independent directors for it. (Reporting by Ananya Mariam Rajesh in... | May 8, 2023